Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial.

Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Safadi MA, Cruz-Valdez A, Litao S, Lim FS, de Los Santos AM, Weber MA, Tinoco JC, Mezerville MH, Faingezicht I, Kosuwon P, Lopez P, Borja-Tabora C, Li P, Durviaux S, Fries L, Dubin G, Breuer T, Innis BL, Vaughn DW.

J Infect Dis. 2014 Aug 15;210(4):545-57. doi: 10.1093/infdis/jiu173. Epub 2014 Mar 20.

PMID:
24652494
[PubMed - in process]
Free PMC Article
2.

Higher Immunological Protection of Pandemic 2009 H1N1 Influenza Live Virus Infection than Split Vaccine Against the Homologous Virus for Long Term Immunization in Ferret.

Zhan L, Deng W, Bao L, Lv Q, Ma C, Li F, Xu L, Qin C.

Indian J Virol. 2012 Dec;23(3):270-7. doi: 10.1007/s13337-012-0076-1. Epub 2012 Sep 28.

PMID:
24293813
[PubMed]
Free PMC Article
3.

Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.

Launay O, Duval X, Fitoussi S, Jilg W, Kerdpanich A, Montellano M, Schwarz TF, Watanveerade V, Wenzel JJ, Zalcman G, Bambure V, Li P, Caplanusi A, Madan A, Gillard P, Vaughn DW.

BMC Infect Dis. 2013 Sep 16;13:435. doi: 10.1186/1471-2334-13-435.

PMID:
24041010
[PubMed - indexed for MEDLINE]
Free PMC Article
4.
5.

Selection of an adjuvant for seasonal influenza vaccine in elderly people: modelling immunogenicity from a randomized trial.

Rümke HC, Richardus JH, Rombo L, Pauksens K, Plaßmann G, Durand C, Devaster JM, Dewé W, Oostvogels L.

BMC Infect Dis. 2013 Jul 26;13:348. doi: 10.1186/1471-2334-13-348.

PMID:
23890405
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults.

Beran J, Peeters M, Dewé W, Raupachová J, Hobzová L, Devaster JM.

BMC Infect Dis. 2013 May 20;13:224. doi: 10.1186/1471-2334-13-224.

PMID:
23688546
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Safety and immunogenicity of 2010–2011 A/H1N1pdm09-containing trivalent inactivated influenza vaccine in adults previously given AS03-adjuvanted H1N1 2009 pandemic vaccine: results of a randomized trial.

Scheifele DW, Dionne M, Ward BJ, Cooper C, Vanderkooi OG, Li Y, Halperin SA; PHAC/CIHR Influenza Research Network.

Hum Vaccin Immunother. 2013 Jan;9(1):136-43.

PMID:
23570051
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study.

Nazareth I, Tavares F, Rosillon D, Haguinet F, Bauchau V.

BMJ Open. 2013 Feb 5;3(2). pii: e001912. doi: 10.1136/bmjopen-2012-001912. Print 2013.

PMID:
23388195
[PubMed]
Free PMC Article
9.

Cross-protection against drifted influenza viruses: options offered by adjuvanted and intradermal vaccines.

Orsi A, Ansaldi F, de Florentiis D, Ceravolo A, Parodi V, Canepa P, Coppelli M, Icardi G, Durando P.

Hum Vaccin Immunother. 2013 Mar;9(3):582-90. Epub 2013 Jan 7.

PMID:
23295230
[PubMed - in process]
Free PMC Article
10.

Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.

Couch RB, Decker WK, Utama B, Atmar RL, Niño D, Feng JQ, Halpert MM, Air GM.

PLoS One. 2012;7(12):e50830. doi: 10.1371/journal.pone.0050830. Epub 2012 Dec 11.

PMID:
23239987
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Immune response to 2009 H1N1 vaccine in HIV-infected adults in Northern Thailand.

Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Wongkulab P, Kaewpoowat Q, Chaiklang K, Kaewthip O, Sroysuwan P, Wongthanee A, Lerdsamran H, Puthavathana P, Suparatpinyo K.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1854-9. doi: 10.4161/hv.21820. Epub 2012 Aug 21.

PMID:
22906932
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Evaluation of immune response following one dose of an AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in Japanese adults 65 years of age or older.

Ikematsu H, Tenjinbaru K, Li P, Madan A, Vaughn D.

Hum Vaccin Immunother. 2012 Aug;8(8):1119-25. doi: 10.4161/hv.21081. Epub 2012 Aug 1.

PMID:
22854661
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.

Duval X, Caplanusi A, Laurichesse H, Deplanque D, Loulergue P, Vaman T, Launay O, Gillard P.

BMC Infect Dis. 2012 Jul 23;12:162. doi: 10.1186/1471-2334-12-162.

PMID:
22824474
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Short and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine.

De Serres G, Gariépy MC, Coleman B, Rouleau I, McNeil S, Benoît M, McGeer A, Ambrose A, Needham J, Bergeron C, Grenier C, Sleigh K, Kallos A, Ouakki M, Ouhoummane N, Stiver G, Valiquette L, McCarthy A, Bettinger J; PHAC-CIHR influenza Research Network (PCIRN).

PLoS One. 2012;7(7):e38563. doi: 10.1371/journal.pone.0038563. Epub 2012 Jul 3.

PMID:
22802929
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons.

Jackson LA, Chen WH, Stapleton JT, Dekker CL, Wald A, Brady RC, Edupuganti S, Winokur P, Mulligan MJ, Keyserling HL, Kotloff KL, Rouphael N, Noah DL, Hill H, Wolff MC.

J Infect Dis. 2012 Sep 15;206(6):811-20. doi: 10.1093/infdis/jis427. Epub 2012 Jul 10.

PMID:
22782949
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O.

BMC Infect Dis. 2012 May 31;12:127. doi: 10.1186/1471-2334-12-127.

PMID:
22650369
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants.

Jul-Larsen Å, Madhun AS, Brokstad KA, Montomoli E, Yusibov V, Cox RJ.

Hum Vaccin Immunother. 2012 May;8(5):653-61. doi: 10.4161/hv.19503. Epub 2012 May 1.

PMID:
22634440
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.

Ikematsu H, Nagai H, Kawashima M, Kawakami Y, Tenjinbaru K, Li P, Walravens K, Gillard P, Roman F.

Hum Vaccin Immunother. 2012 Feb;8(2):260-6. doi: 10.4161/hv.18469. Epub 2012 Feb 1.

PMID:
22426369
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Effect of lipoarabinomannan from Mycobacterium avium subsp avium in Freund's incomplete adjuvant on the immune response of cattle.

Colavecchia SB, Jolly A, Fernández B, Fontanals AM, Fernández E, Mundo SL.

Braz J Med Biol Res. 2012 Feb;45(2):139-46. Epub 2012 Feb 2.

PMID:
22286534
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.

Baz M, Samant M, Zekki H, Tribout-Jover P, Plante M, Lanteigne AM, Hamelin ME, Mallett C, Papadopoulou B, Boivin G.

Clin Vaccine Immunol. 2012 Feb;19(2):209-18. doi: 10.1128/CVI.05441-11. Epub 2011 Dec 21.

PMID:
22190392
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk